To develop an efficacious and efficient method for treating chronic wounds using “nanosheet” that improves the survival and localization of transplanted cells without prior seeding to optimally derive the regenerative potentials of uncultured stromal vascular fraction (SVF) cells.
Approach:
We propose a method whereby the wound is covered by uncultured SVF cells using the nanosheet [porous poly(d, l,-lactic acid)] (PDLLA) films) designed to hold cells in a single-cell layer. A chronic wound model was created on 12-month-old db/db mice by inflecting a full-thickness skin excision on their dorsum and was subsequently given either no treatment or a treatment with SVF cells alone (with Tegaderm dressing), nanosheet alone, or nanosheet with SVF cells.
Results:
The placement of the nanosheet improved the grafted cell retention rate at day 10 timepoint by 5 folds, and the wound area was the smallest in the wounds treated with SVF cells plus nanosheet in comparison to the other groups. Collagen deposition and epidermal growth factor were significantly higher in the wound beds treated with SVF cells with the nanosheet, offering some mechanistic insights.
Innovation:
Porous poly(d, l,-lactic acid acid) (PDLLA) films or “nanosheet” printed on the nanoscale (1–100 nm in thickness) as a cellular scaffold for cytotherapy for the treatment of chronic wounds.
Conclusion:
The use of the nanosheet is an effective way to improve the transplanted SVF cell retention and accelerate the overall wound closure.
Get full access to this article
View all access options for this article.
References
1.
KimHR, HanSK, RhaSW, et al..Effect of percutaneous transluminal angioplasty on tissue oxygenation in ischemic diabetic feet. Wound Repair Regen, 2011; 19(1):19–24; doi: 10.1111/j.1524-475X.2010.00641.x
2.
ParkDJ, HanSK, KimWK. Is the foot elevation the optimal position for wound healing of a diabetic foot? J Plast Reconstr Aesthet Surg, 2010; 63(3):561–564; doi: 10.1016/j.bjps.2008.11.042
3.
NuutilaK, KatayamaS, LaitinenA, et al.ATMP-classified, scalable, autologous cell spray for the treatment of skin wounds and assessment of its effects on wound healing clinically and on a molecular level. Burns, 2023; 49(5):1144–1156; doi: 10.1016/j.burns.2022.09.006
4.
GravanteG, Di FedeMC, AracoA, et al.A randomized trial comparing ReCell® system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns. Burns, 2007; 33(8):966–972; doi: 10.1016/j.burns.2007.04.011
5.
WoodFM, GilesN, StevensonA, ReaS, FearM. Characterisation of the cell suspension harvested from the dermal epidermal junction using a ReCell® kit. Burns, 2012; 38(1):44–51; doi: 10.1016/j.burns.2011.03.001
6.
RheinwatdJG, GreenH. Seria cultivation of strains of human epidemal keratinocytes: The formation Keratinizin colonies from single cell is. Cell, 1975; 6(3):331–343; doi: 10.1016/S0092-8674(75)80001-8
7.
YouHJ, HanSK. Cell therapy for wound healing. J Korean Med Sci, 2014; 29(3):311–319; doi: 10.3346/jkms.2014.29.3.311
8.
NguyenA, GuoJ, BanyardDA, et al.Stromal vascular fraction: A regenerative reality? Part 1: Current concepts and review of the literature. J Plast Reconstr Aesthet Surg, 2016; 69(2):170–179; doi: 10.1016/j.bjps.2015.10.015
9.
FDA. 2020. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: Minimal manipulation and homologous use; Guidance for Industry and Food and Drug Administration Staff, Food and Drug Administration.
10.
HanS, SunHM, et al.Adipose-derived stromal vascular fraction cells: Update on clinical utility and efficacy. Crit Rev Eukaryot Gene Expr, 2015; 25(2):145–152; doi: 10.1615/CritRevEukaryotGeneExpr.2015013057
11.
YouHJ, HanSK, et al.Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes - A pilot study. Wound Repair Regen, 2012; 20(4):491–499; doi: 10.1111/j.1524-475X.2012.00809.x
12.
GallegoL, JunqueraL, VillarrealP, et al.Use of cultured human epithelium for coverage: A defect of radial forearm free flap donor site. Med Oral Patol Oral Cir Bucal, 2010; 15(1):e58–e60; doi: 10.4317/medoral.15.e58
13.
YanagaH, UdohY, YamauchiT, et al.Cryopreserved cultured epidermal allografts achieved early closure of wounds and reduced scar formation in deep partial-thickness burn wounds (DDB) and split-thickness skin donor sites of pediatric patients. Burns, 2001; 27(7):689–698; doi: 10.1016/S0305-4179(01)00008-0
14.
HanSK, ChoiKJ, KimWK. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: A pilot study. Plast Reconstr Surg, 2004; 114(7):1783–1789; doi: 10.1097/01.PRS.0000142415.57470.DF
15.
HanSK, KimWK. Revisiting fresh fibroblast allograft as a treatment for diabetic foot ulcers. Plast Reconstr Surg, 2009; 123(2):88e–89e; doi: 10.1097/PRS.0b013e3181959701
16.
HanSK, KimHS, KimWK. Efficacy and safety of fresh fibroblast allografts in the treatment of diabetic foot ulcers. Dermatologic Surg, 2009; 35(9):1342–1348; doi: 10.1111/j.1524-4725.2009.01239.x
17.
HanSK, KimHR, KimWK. The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: A pilot study. Wound Repair Regeneration, 2010; 18(4):342–348; doi: 10.1111/j.1524-475X.2010.00593.x
18.
DuscherD, BarreraJ, WongVW, et al.Stem cells in wound healing: The future of regenerative medicine? A mini-review. Gerontology, 2016; 62(2):216–225; doi: 10.1159/000381877
19.
KirbyGTS, MillsSJ, CowinAJ, et al.Stem cells for cutaneous wound healing. Biomed Res Int, 2015; 2015:285869; doi: 10.1155/2015/285869
20.
ChenYW, ScutaruTT, GhetuN, et al.The effects of adipose-derived stem cell-fifferentiated adipocytes on skin burn wound healing in rats. J Burn Care Res, 2017; 38(1):1–10.
21.
SeoE, LimJS, JunJB, et al.Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing. J Transl Med, 2017; 15(1):35; doi: 10.1186/s12967-017-1145-4
22.
BiH, LiH, ZhangC, et al.Stromal vascular fraction promotes migration of fibroblasts and angiogenesis through regulation of extracellular matrix in the skin wound healing process. Stem Cell Res Ther, 2019; 10(1); doi: 10.1186/s13287-019-1415-6
23.
RamakrishnanVM, BoydNL. The adipose stromal vascular fraction as a complex cellular source for tissue engineering applications. Tissue Eng Part B Rev, 2018; 24(4):289–299; doi: 10.1089/ten.teb.2017.0061
24.
Di RoccoG, GentileA, AntoniniA, et al.Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: Biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int, 2011; 2011:304562; doi: 10.4061/2011/304562
25.
FujieT. Development of free-standing polymer nanosheets for advanced medical and health-care applications. Polym J, 2016; 48(7):773–780; doi: 10.1038/pj.2016.38
26.
SuzukiS, NishiwakiK, TakeokaS, et al.Large-scale fabrication of porous polymer nanosheets for engineering hierarchical cellular organization. Adv Materials Technologies, 2016; 1(6); doi: 10.1002/admt.201600064
27.
NishiwakiK, AokiS, KinoshitaM, et al.In situ transplantation of adipose tissue-derived stem cells organized on porous polymer nanosheets for murine skin defects. J Biomed Mater Res B Appl Biomater, 2019; 107(5):1363–1371; doi: 10.1002/jbm.b.34228
28.
HamdanS, PastarI, DrakulichS, et al.Nanotechnology-driven therapeutic interventions in wound healing: Potential uses and applications. ACS Cent Sci, 2017; 3(3):163–175; doi: 10.1021/acscentsci.6b00371
29.
MiyazakiH, KinoshitaM, SaitoA, et al.An ultrathin poly(L-lactic acid) nanosheet as a burn wound dressing for protection against bacterial infection. Wound Repair Regen, 2012; 20(4):573–579; doi: 10.1111/j.1524-475X.2012.00811.x
30.
MichaelsJ, ChurginSS, BlechmanKM, et al.db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regeneration, 2007; 15(5):665–670; doi: 10.1111/j.1524-475X.2007.00273.x
31.
TrousdaleRK, JacobsS, SimhaeeDA, et al.Wound closure and metabolic parameter variability in a db/db Mouse Model for Diabetic Ulcers. J Surg Res, 2009; 151(1):100–107; doi: 10.1016/j.jss.2008.01.023
SenCK. Human wounds and its burden: An updated compendium of estimates. Adv Wound Care (New Rochelle), 2019; 8(2):39–48; doi: 10.1089/wound.2019.0946
34.
RichmondNA, MaderalAD, VivasAC. Evidence-based management of common chronic lower extremity ulcers. Dermatol Ther, 2013; 26(3):187–196; doi: 10.1111/dth.12051
35.
Optimal Care of Chronic, Non-Healing, Lower Extremity Wounds: A Review of Clinical Evidence and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Dec 17.
36.
CardinalM, EisenbudDE, ArmstrongDG, et al.Serial surgical debridement: A retrospective study on clinical outcomes in chronic lower extremity wounds: Original research – clinical science. Wound Repair Regeneration, 2009; 17(3):306–311; doi: 10.1111/j.1524-475X.2009.00485.x
37.
Dalla PaolaL, CaroneA, ValenteM, et al.Surgical OFF-LOADING of the diabetic foot. J Clin Orthop Trauma, 2021; 16:182–188; doi: 10.1016/j.jcot.2021.01.005
EaglsteinWH, FalangaV. Tissue engineering and the development of Apligraf, a human skin equivalent. Clin Ther, 1997; 19(5):894–905; doi: 10.1016/s0149-2918(97)80043-4
40.
GentileP, CalabreseC, De AngelisB, PizzicannellaJ, KothariA, GarcovichS. Impact of the different preparation methods to obtain human adipose-derived stromal vascular fraction cells (AD-SVFs) and human adipose-derived mesenchymal stem cells (AD-MSCs): Enzymatic digestion versus mechanical centrifugation. Int J Mol Sci, 2019; 20(21); doi: 10.3390/ijms20215471
41.
GentileP, SterodimasA, CalabreseC, et al.Stem Cell Res Ther Advances of fat tissue engineering as bioactive scaffold, bioactive material, and source for adipose-derived mesenchymal stem cells in wound and scar treatment. Stem Cell Res Ther, 2021; 12(1):318; doi: 10.1186/s13287-021-02397-4
42.
GentileP, CasellaD, PalmaE, et al.Engineered Fat Graft Enhanced with Adipose-derived Stromal Vascular Fraction cells for regenerative medicine: Clinical, histological and instrumental evaluation in breast reconstruction. J Clin Med, 2029; 8(4); doi: 10.3390/jcm8040504
43.
ScioliMG, BielliA, GentileP, et al.The biomolecular basis of adipogenic differentiation of adipose-derived stem cells. Int J Mol Sci, 2024; 15(4); doi: 10.3390/ijms1504651
44.
GentileP, GarcovichS. Concise review: Adipose-derived stem cells (ASCs) and Adipocyte-secreted exosomal microRNA (A-SE-miR) modulate cancer growth and proMote wound repair. J Clin Med, 2019; 8(6); doi: 10.3390/jcm8060855
45.
ScioliMG, StortiG, D’AmicoF, et al.Adipose-derived stem cells in cancer progression: New perspectives and opportunities. Int J Mol Sci, 2019; 20(13); doi: 10.3390/ijms20133296
